Market Talk
This is a quick market talk today. This weekend we heard reports of both Donald and Nancy saying there may be 2 more days to work a deal on Covid 19 stimulus. Last week we heard the treasury secretary say no deal till "after the election". Here is my take, neither the republicans or the democrats agree on the specifics of just who gets it and how much. The democrats seem to want to bail out the long-standing ailments caused by a history of overspending of democrat states and policy whereas the republicans want to stay with helping the economy and people get over the hump caused by the C19 pandemic.
I am doubtful there will be an agreement before the election and each party will blame the other on a poor state of affairs in country. I am cautious on the market, making me feel like a "curb your enthusiasm " mode is in warranted. Meanwhile C19 is re-surging in many areas of America and all around the world.
In politics, sometimes, Trump's judgement is "off" as to the way he presents himself. But still, I can't get behind the radical agenda of the liberal left socialists that claim they will control "good ol' Joe".
Stock Talk
With the above, this is my take on some stocks I am watching and now trading. My position on Inovio stands for the near term to see if the following bullet point can play out:
- Inovio (INO) - waiting on the FDA hold of C19 vaccine INO4800 due to their questions on the device called Cellectra to administer the vaccine. This device has been used many times in previous trials and led to a successful outcome with EUA approval of their Mers vaccine INO4700 in S. Korea. Both C19 and Mers are a similar sars virus. I suspect the Inovio replies to the FDA were submitted. I am waiting for the hold on Phase 2/3 of INO4800 to be lifted. While the FDA has 30 days to reply it could be sooner. My hope is that the FDA reply favorably at any moment or day considering that other widely touted vaccines from big Pharma are fledgling and held with Adverse Effects. I still believe that Inovio's INO4800 may be the safest and most effective against C19 and variants. I am basing this view on the DNA vaccine providing a more balanced natural protection with both neutralizing antibodies and targeted T- fighter cells of the immune system.
My take on SRNE remains but the recent fade in share price and short attacks putting the CEO Dr. Ji on the spot to deliver something. I am using the FDA clearance to start STI 1499 antibody as my metric as a gauge of truth or BS. This is what I was and still am looking for but my enthusiasm is curbed by the recent downtrend of share price wondering if the short thesis has some merit.
- Sorrento (SRNE)
- waiting on the imminent C19 patients in hospitals to receive the
Phase 1 antibody STI 1499 in a one or two shot and recover quickly from
C19. I am waiting for these people to walk out of the hospital talking
about the Sorrento shot that made them feel better. (as time goes on and the sp dwindles- my enthusiasm is being curbed.)
- Yamana Gold (AUY): I am buying a few shares of this gold and silver miner. It is now in the $5's the lower range of its recent trading between the 5's and 6's. With Gold and silver at the higher range, and increased production estimates and recent dividend increase, I suspect some AUY may be fair bet to hold some shares in a dicey market.
When I lose faith in some stocks like I did on Vaxart,
I am tending to put some of that sale proceeds into AUY and $ cost
average into the less volatile Gold and silver miner "to see".
Now my overall enthusiasm is curbed. However, I still especially await as a "long" in "just some" INO shares to see if the hold on INO4800 vaccine is to be lifted by the FDA. In the meantime I am wondering if the FDA will be chagrined if S. Korea , China or Australia were to suddenly announce an Emergency Use Authorization (EUA) for Inovio's vaccine in ongoing trials, not halted.
I hate curbing my enthusiasm but I equally dislike losing share value and when warranted if I have to trim some shares to go to cash or something else, I will. It's up to the companies to either perform to expectations or not and when not, we all have to make some tough decisions.
______
ALL in my humble opinion, scroll down and read more..This site does NOT make Buy / Sell recommendations.
___